Approvals/TGA/FEIBA-NF factor VIII inhibitor bypassing fraction 2500U powder for injection vial with diluent vial

Approved

STANDARD

FEIBA-NF factor VIII inhibitor bypassing fraction 2500U powder for injection vial with diluent vial

Takeda Pharmaceuticals Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 628b6bb53d355fb7
Product Name: FEIBA-NF factor VIII inhibitor bypassing fraction 2500U powder for injection vial with diluent vial
Artg Id: 172236
Artg Name: FEIBA-NF factor VIII inhibitor bypassing fraction 2500U powder for injection vial with diluent vial
Sponsor: Takeda Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/takeda-pharmaceuticals-australia-pty-ltd
Artg Date: 2012-03-30
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/366064d24abb64e9991bf0fe9b5bbb2d.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/e1a4362e8456863b6573636ada4b6a50.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

628b6bb53d355fb7

Type

Standard